Innate Pharma S.A.

NASDAQ: IPHA · Real-Time Price · USD
2.11
-0.07 (-3.21%)
At close: Aug 15, 2025, 3:59 PM
2.12
0.47%
After-hours: Aug 15, 2025, 04:00 PM EDT

Innate Pharma S.A. Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-24.71M -24.76M -9.29M 1.72M -64.35M 6.38M -21.76M -23.72M
Depreciation & Amortization
852K 1.14M 1.45M 3.65M 2.38M 2.04M 2.38M 2.19M
Stock-Based Compensation
2.24M 1.71M 2.85M 700.5K 826.5K 1.3M 882K 426.5K
Other Working Capital
39.69M -528K -3.38M -10.61M -12.86M 12.22M -5.67M -6.66M
Other Non-Cash Items
3.83M -6.36M -3.06M 16.91M 36.72M 30.89M -14.21M 13.29M
Deferred Income Tax
n/a n/a -27.92M -15.91M 5.74M -28.58M n/a n/a
Change in Working Capital
7.85M 31.31M -13.05M -18.53M -1.53M -10.98M 2.75M -12.64M
Operating Cash Flow
-9.93M 3.04M -21.09M -11.46M -20.2M 1.05M -27.17M -31.24M
Capital Expenditures
-108K -283K -42K -312K -702K -421K -995K -336K
Cash Acquisitions
n/a n/a 300K n/a n/a n/a 5K 2K
Purchase of Investments
n/a n/a -2 n/a n/a n/a n/a n/a
Sales Maturities Of Investments
9.59M n/a 45.54M n/a 3M n/a n/a n/a
Other Investing Acitivies
-1.21M 1.22M 20.92M 66K 1.19M 12.5K 40K -3.5K
Investing Cash Flow
8.27M 932K 20.88M -246K 2.3M -420K -951K -333K
Debt Repayment
-8.94M n/a n/a n/a -1.07M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
7.44M -4.51M -1.53M -1.25M 6K -958K 28.2M -1.13M
Financial Cash Flow
-1.68M -4.33M -720K -1.25M -1.06M -766K 28.2M -1.07M
Net Cash Flow
-3.59M 69.99M -809K -12.81M -18.72M -807K -224K -32.81M
Free Cash Flow
-10.04M 2.75M -21.14M -11.78M -20.91M 628K -28.16M -31.57M